Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Induction Dosage in Latent Phase of Labor
NCT03742531Phase 2Completed
- Sponsor
- Zeynep Kamil Maternity and Pediatric Research and Training Hospital
- Start
- Dec 2018
- Primary completion
- Jun 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxytocin in labor induction (2 arms), sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital. Primary endpoint: Need for oxytocin retreatment in active phase of labor. Started Dec 2018; status: completed.
02
Drugs
oxytocin
03
Conditions
labor induction
Beyond the preview
Go deeper on NCT03742531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742531.